Amelie Gubitz, Ph.D.

Job Title
Program Director
Amelie Gubitz, Ph.D.
Division of Neuroscience
Neurodegeneration Dementia and Repeat Expansion Disorders
Areas of Interest

Amyotrophic Lateral Sclerosis (ALS), Spinal and Bulbar Muscular Atrophy, Hereditary Spastic Paraplegia, Friedreich’s Ataxia

Contact Email
Contact Number

Dr. Amelie Gubitz serves as a Program Director in the Neurodegeneration Cluster of the Division of Neuroscience. Her portfolio includes basic, translational and clinical research on amyotrophic lateral sclerosis, X-linked spinal and bulbar muscular atrophy, hereditary spastic paraplegia and Friedreich's ataxia. Dr. Gubitz earned a Ph.D. in pharmacology from the University of Cambridge, UK, and then completed a Wellcome Trust Fellowship at Harvard Medical School in circadian biology. She has also worked as a Senior Scientist in the target discovery group for neuropathic pain at Parke Davis, UK, and as a Research Assistant Professor at the University of Pennsylvania where she studied the molecular pathogenesis of spinal muscular atrophy.